Your browser doesn't support javascript.
loading
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
Wagner, Michael J; Pollack, Seth M; Cranmer, Lee D; Thompson, Matthew J; Maxwell, Shannon; Wright, Stephanie; Khaki, Ali R; Madeleine, Margaret M; Grivas, Petros; Kuderer, Nicole M; Lyman, Gary H; Loggers, Elizabeth T.
Afiliação
  • Wagner MJ; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Pollack SM; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Cranmer LD; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Thompson MJ; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Maxwell S; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Wright S; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Khaki AR; Department of Orthopedic Surgery, University of Washington, Seattle, Washington, USA.
  • Madeleine MM; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Kuderer NM; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Lyman GH; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Loggers ET; Department of Epidemiology, University of Washington and Public Health Sciences Division, FHCRC, Seattle, Washington, USA.
Cancer Invest ; 39(4): 315-320, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33720792
Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Invest Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos